Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.
Ingredion Q2 Earnings Call Highlights
Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.
Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates
Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.
Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?
Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.
How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook
Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.
Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Britain's Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) offer from U.S. rival Ingredion , the companies said on Monday, creating a food and beverage ingredients major.
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
Ingredion: Oversold After Argo Issues, Acquisition Could Change The Story
Ingredion Incorporated (INGR) remains a Buy, supported by strong financials and robust cash generation despite recent operational setbacks and macro pressures. Q1 results were weak due to Argo facility issues, leading to reduced 2026 guidance and highlighting operational and cost risks. Potential acquisition of Tate & Lyle could transform INGR, expanding geographic reach significantly and helping to diversify into higher-growth segments.
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.
